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Abstract
Well differentiated liposarcoma (atypical lipomatous tumour) is a low grade tumour, with no metastatic potential unless
dedifferentiation supervenes. When superficial, it recurs locally only occasionally after marginal excision. We present a
patient in whom bilateral childhood retinoblastoma was followed by later development of massive confluent areas of low
grade liposarcoma and lipomatous tissue affecting the upper extremities and trunk. We discuss the role of mutations in the
retinoblastoma gene (RB1) in linking these conditions and demonstrate the surgical management of an extremely unusual
and challenging case.
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Case report
A 49-year-old man presented to us in January 2003
with a fatty pedunculated lesion in the left axilla. He
had a past history of multiple similar lesions (some of
which recurred after initial excision) over his
shoulders, upper back and arms. Operations to
excise them were undertaken in 1979, 1985, 1993
and 1997. Clinically the lesions removed were
superficial, discrete and mobile. These lumps devel-
oped on a background of abnormally large fatty
tissue over shoulders, back and anterior chest which
began to develop and increase gradually in size over
the past 6 years. On examination he was found to
have an extraordinary appearance with an unusual fat
distribution. His large shoulders and buffalo hump
back were clearly out of proportion to the rest of his
habitus (Figure 1). He weighed 19.5 stone and was
5ft 7.5inches tall.
The lesion arising from the left axilla was excised
under general anaesthetic as a daycase in April 2003.
The patient had a history of bilateral retino-
blastoma diagnosed at 21 months of age. In order
to treat this, he received radiotherapy to the right
eye and underwent enucleation of the left eye.
There was no known family history of retinoblas-
toma or other tumours.
Histologically, a spectrum is seen within the
tumours: areas typical of well differentiated liposar-
coma (atypical lipomatous tumours) merge imper-
ceptibly towards the periphery with histologically
normal adipose tissue. The tumours include areas of
increased cellularity with occasional atypical cells
particularly in relationship to fibrotic bands running
through the lesions (Figure 2(a)). In addition there is
much variability in adipocyte size and shape and very
occasional cells consistent with lipoblasts are seen
(Figure 2(b)).
MR imaging was performed in June 2003 to
assess the extent of the remaining swellings in
his shoulders neck and arms. His shoulders were
too large to fit into the body coil of the local
MRI Scanner (Siemens 1.0T Magnetron Impact,
Erlangen, Germany) and therefore imaging was
performed at a different hospital on an ‘open MRI
scanner’ (Siemens 0.2T OR10 Magnatron Open
Resistive, Erelangen, Germany) which does not
have the same physical constraints. This allowed
each shoulder to be studied separately and then
the thorax was scanned with his arms raised out of
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DOI: 10.1080/13577140500229596the coil. Both shoulders showed marked fatty
thickening in the subcutaneous tissues and this
thickening passed along the arms and to the anterior
chest wall. There was no evidence of abnormal
fat deep to the muscle layers. Margins were not
clearly defined between lesions and the whole mass
of tissue appeared homogeneous. The STIR
sequences best demonstrated the irregular nature of
the swelling arising from the right axilla with
a lobulated appearance and oedematous fluid within.
T1 coronal images of both his shoulder girdles
demonstrated the lobulated fatty soft tissue masses
(Figure 3).
With regard to the liposarcomas, no further
surgery or adjuvant therapy was planned. The patient
was warned about the risk of dedifferentiation and
continues on clinical follow up to check for any
discrete, rapidly enlarging or painful nodules. Some
further debulking to non-specific areas of lipodystro-
phy is currently being planned at the patient’s
request to aid mobility and cosmesis.
Discussion
This is a case of a man with bilateral retinoblas-
tomas, multiple liposarcomas (atypical lipomatous
Figure 1. (a) Anterior view of abnormal body habitus and lipodystrophy. The fatty pedunculated lesion is visible in the left axilla.
(b) Posterior view. A scar from previous surgery can be seen across the upper back.
152 J. K. O’Neill et al.tumours), excess lipomatous tissue and an unusual
body habitus. Retinoblastoma tumours are fre-
quently caused by mutations of the RB1 tumour
suppressor gene situated at chromosome 13q14.1
[1–3]. Most patients with bilateral disease have a
germline (inherited) mutation of one copy of the
gene. Tumours arise after a ‘second hit’ phenom-
enon producing a mutation on the other allele in
retinal cells. Although there is no family history to
suggest that previous generations of this man’s family
had the RB1 gene mutation, the presence of bilateral
disease suggests that he has the familial form
(whether inherited or occurring as a spontaneous
new mutation) with a germline mutation affecting
each cell.
The RB1 gene encodes a tumour suppressor
protein which is present in all normal cell lines [1].
The RB1 gene protein actively regulates the cell cycle
by acting as a brake in the advancement of cells
from the G1 to the S phase of the cycle. It plays a
critical role in determining cell cycle progression.
If the RB1 protein is absent (due to mutations
occurring in both copies of the gene) then progres-
sion into S phase occurs unchecked and cell
proliferation is increased [1].
Retrospective cohort studies [4,5] have found that
patients with bilateral retinoblastoma and, to a lesser
extent unilateral retinoblastoma, have an increased
risk of death from second primary neoplasms,
particularly sarcomas of bone and connective tissue,
skin melanomas and brain tumours. Radiotherapy
as a primary treatment for retinoblastoma appears
to further enhance the inborn susceptibility to
develop a second cancer [4].
Figure 2. Photomicrographs of representative sections of the tumour stained with haematoxylin and eosin. (a) A fibrotic band is visible on
this section. (b) A lipoblast cell is shown.
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hereditary retinoblastoma is about 13% [6,7].
Two large series of patients with retinoblastoma
have found previous cases of liposarcoma (one
retroperitoneal) [7,8].
Deletions and structural rearrangements of regions
on the long arm chromosome 13 near the RB1 locus
have already been found to confer susceptibility to
formation of benign and malignant lipomatous
tumours (ordinary lipoma, spindle cell/pleomorphic
Figure 3. (a) STIR Axial image of right axilla demonstrating the irregular nature of the swelling arising from the right
axilla. (b) Coronal T1 Image of the right shoulder demonstrating the lobulated fatty soft tissue masses arising in the subcutaneous
fat over deltoid.
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coma) [2].
Multiple lipomas are reported to be associated
with hereditary retinoblastoma [6,9,10]. Hereditary
retinoblastoma patients with lipomas have a
greater frequency (30%) of second malignant neo-
plasms (including malignant fibrous histiocytoma,
leiomyosarcoma and fibrosarcoma) compared with
patients in whom lipomas are not an associated
feature (risk of approximately 13%) [6]. The
sarcomas originated at sites separate from pre-
existing lipomas, except for one patient with a scrotal
leiomyosarcoma [6].
The lipomas associated with retinoblastoma may
differ in presentation from other lipomatoses [10],
such as familial multiple lipomatosis and benign
cervical lipomatosis. RB-associated lipomas tend to
be discrete and mobile lesions (as in familial multiple
lipomatosis) and contrast with the diffuse fatty
infiltration seen in benign cervical lipomatosis.
Lipomas in patients with RB are distributed pre-
dominantly over the face, neck, shoulders and upper
chest (as in benign cervical lipomatosis), but in
familial multiple lipomatosis these areas are mostly
spared. We report a more generalised abnormal
upper body fat distribution with superadded discrete
and mobile tumours.
Cytogenetic and molecular genetic evidence for
the link between germline RB1 mutations and
lipomas was initially revealed by FISH and micro-
satellite studies that showed that the DNA in the
lipomas from patients with retinoblastoma had lost
heterozygosity of the RB1 gene [9].
Molecular studies have also demonstrated an
extended genetic family segregating a splice site
mutation in the RB1 gene [10]. Almost all the adult
carriers of this mutation have multiple lipomas with
incomplete penetrance of retinoblastoma. However,
this RB1 gene mutation has also been reported in a
pedigree family in whom there were no lipomas [6].
This indicates that the lipoma predisposition in
hereditary retinoblastoma may not be due to a
specific RB1 gene mutation but be influenced
by modifying factors linked to this gene. A specific
allele of a modifying factor may cause lipoma
predisposition in carriers of the oncogenic RB1
gene mutation.
There may be a similar genetic mechanism in this
patient whereby the mutation in his RB1 gene makes
him susceptible to a modifying factor predisposing to
liposarcoma.
Alternatively there could be a ‘second hit’ (muta-
tion of the second retinoblastoma gene) in already
existing lipoma cells that causes them to develop into
liposarcoma. This is the mechanism by which retina
cells develop retinoblastoma.
The DNA from blood and tumour was harvested
for study in our patient. So far, although a germline
mutation has been found in the blood DNA, the
tumour studies have not shown loss of heterozygos-
ity. This implies that the genetic mechanism is likely
to be susceptibility to a modifying factor rather than a
‘second hit’.
With regards to the clinical management of this
patient, clearance of the tumour is probably impos-
sible because the margin of the tumour cannot
be delineated radiologically. The probability of
de-differentiation to a higher grade tumour is
unlikely but possible. De-differentiated liposarcoma
occurs most frequently (over 75% of cases) in intra-
abdominal locations (most commonly in the retro-
peritoneum), deep soft tissues of the extremities
(15%) and the trunk (7%), and is very rarely seen in
subcutaneous adipose tissue [11–13]. In a series of
155 cases of liposarcoma that de-differentiated to
high grade, three were subcutaneous [12]. These
subcutaneous tumours behave much less aggressively
than the retroperitoneal tumours or those in
the deep soft tissues [11,12]. Well differentiated
liposarcomas have no known metastatic potential
[14]. Metastasis would only be likely to occur after
de-differentiation.
The management of this case can be compared to
that of patients who have numerous unresectable
neurofibromas with the risk of tumour progression to
high grade malignancy.
The patient has been warned that there is a
possibility of de-differentiation to a higher grade
tumour. Patient self assessment and regular checks in
the outpatient clinic are being carried out to identify
firm or rapidly growing nodules or painful nodules if
they develop.
Conclusion
To summarise, germline retinoblastoma mutations
in certain patients with hereditary retinoblastoma
increase their susceptibility to developing benign
tumours such as lipomas as well as malignant
neoplasms, including soft tissue sarcomas such as
liposarcoma. Patients with retinoblastoma and
lipomas are even more at risk of developing
further neoplasms. The possibility of either
de-differentiation of the liposarcoma, or the devel-
opment of a further primary malignancy are concerns
for the future.
In conclusion, we describe a patient with extra-
ordinary body habitus and a history of multiple fatty
tumours, both benign and low grade malignant. He
had a past history of bilateral retinoblastomas. The
complex management issues related to this patient
are manifest.
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